Huanma Bio-Pharmaceutical Co
At a glance
- Status
- Operational
- Open positions
- None listed
- Dealroom signal
- 14.0/100
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Dec 2021 | $20M | $80M | Yifeng Capital · Xianfeng Cowin · Kunlun Capital | ↗ |
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Huanma Bio-Pharmaceutical Co in its local ecosystem
The Huanma Bio-Pharmaceutical Co office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
- XCXianfeng Cowin
- YCYifeng Capital
Kunlun Capital
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Huanma Bio-Pharmaceutical Co on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Huanma Bio-Pharmaceutical Co’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.